The effects of polyphenol supplementation on adipose tissue morphology and gene expression in overweight and obese humans.
Jasper MostInes WarnkeMark V BoekschotenJohan W E JockenPhilip de GrootAngelika FriedelIgor BendikGijs H GoossensEllen E BlaakPublished in: Adipocyte (2018)
Dietary polyphenols have beneficial effects on adipose tissue mass and function in rodents, but human studies are scarce. In a randomized, placebo-controlled study, 25 (10 women) overweight and obese humans received a combination of the polyphenols epigallocatechin-gallate and resveratrol (282 mg/d, 80 mg/d, respectively, EGCG+RES, n = 11) or placebo (PLA, n = 14) supplementation for 12 weeks. Abdominal subcutaneous adipose tissue (SAT) biopsies were collected for assessment of adipocyte morphology and micro-array analysis. EGCG+RES had no effects on adipocyte size and distribution compared with PLA. However, we identified pathways contributing to adipogenesis, cell cycle and apoptosis were significantly downregulated by EGCG+RES versus PLA. Furthermore, EGCG+RES significantly decreased expression of pathways related to energy metabolism, oxidative stress, inflammation, and immune defense as compared with PLA. In conclusion, the SAT gene expression profile indicates a reduced cell turnover after 12-week EGCG+RES in overweight-obese subjects. It remains to be elucidated whether these alterations translate into long-term metabolic effects.
Keyphrases
- adipose tissue
- oxidative stress
- cell cycle
- insulin resistance
- gene expression
- high fat diet
- endothelial cells
- polycystic ovary syndrome
- cell proliferation
- poor prognosis
- dna damage
- single cell
- physical activity
- dna methylation
- endoplasmic reticulum stress
- cell death
- copy number
- high throughput
- cell therapy
- high fat diet induced
- type diabetes
- binding protein
- clinical trial
- bone mineral density
- pregnant women
- bariatric surgery
- mesenchymal stem cells
- skeletal muscle
- randomized controlled trial
- stem cells
- open label
- bone marrow
- signaling pathway
- obese patients